Analysis of Hyperthermia as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Carpal Tunnel Syndrome:
Launched by UNIVERSITY OF MALAGA · Apr 16, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment approach for Carpal Tunnel Syndrome (CTS), a condition that causes pain and numbness in the hand due to pressure on a nerve in the wrist. The study will explore the effects of a therapy that uses heat, called hyperthermia, combined with physical exercises and a night splint. Participants will be divided into four groups: two groups will receive two or three sessions of treatment per week that include hyperthermia, while the other two groups will receive the same exercises and splint without the heat, also in two or three sessions per week. Researchers will measure changes in muscle strength, wrist movement, and overall hand function through questionnaires and physical tests.
To join the study, participants need to be between the ages of 18 and 75 and must have a confirmed diagnosis of Carpal Tunnel Syndrome. It's important that they haven't received physical therapy before and have not undergone surgery related to this condition. Those with certain medical issues or muscle weakness related to CTS will not be eligible. The trial aims to understand how effective this heat therapy is and whether more frequent sessions improve results. If you're interested in participating, keep in mind that the study is not yet recruiting, so check back for updates!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have a diagnosis confirmed by performing an electromyography of Carpal Tunnel Syndrome
- • Have not yet received physiotherapy treatment.
- Exclusion Criteria:
- • Have undergone surgery.
- • Those who refuse to participate in this study.
- • Patients with muscle atrophy due to CTS.
- • Medical conditions that are contraindications for hyperthermia therapy.
About University Of Malaga
The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported